London
· Delayed Price · Currency is GBP · Price in GBXAbingdon Health Statistics
Total Valuation
Abingdon Health has a market cap or net worth of GBP 28.31 million. The enterprise value is 27.92 million.
| Market Cap | 28.31M |
| Enterprise Value | 27.92M |
Important Dates
The next estimated earnings date is Friday, December 13, 2024.
| Earnings Date | Dec 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Abingdon Health has 385.16 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 385.16M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 7.06% |
| Owned by Institutions (%) | 19.53% |
| Float | 164.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.65 |
| PB Ratio | 10.10 |
| P/TBV Ratio | 16.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.97 |
| EV / Sales | 4.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.48 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.95 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.62 |
| Interest Coverage | -29.74 |
Financial Efficiency
Return on equity (ROE) is -48.69% and return on invested capital (ROIC) is -27.54%.
| Return on Equity (ROE) | -48.69% |
| Return on Assets (ROA) | -17.93% |
| Return on Capital (ROIC) | -27.54% |
| Revenue Per Employee | 73,036 |
| Profits Per Employee | -15,131 |
| Employee Count | 84 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 6.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.53% |
| 50-Day Moving Average | 8.24 |
| 200-Day Moving Average | 9.52 |
| Relative Strength Index (RSI) | 40.19 |
| Average Volume (20 Days) | 150,153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abingdon Health had revenue of GBP 6.14 million and -1.27 million in losses. Loss per share was -0.00.
| Revenue | 6.14M |
| Gross Profit | 3.68M |
| Operating Income | -1.61M |
| Pretax Income | -1.40M |
| Net Income | -1.27M |
| EBITDA | -1.25M |
| EBIT | -1.61M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.44 million in cash and 1.05 million in debt, giving a net cash position of 391,000 or 0.00 per share.
| Cash & Cash Equivalents | 1.44M |
| Total Debt | 1.05M |
| Net Cash | 391,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.25M |
| Book Value Per Share | 0.01 |
| Working Capital | 1.72M |
Cash Flow
In the last 12 months, operating cash flow was -1.66 million and capital expenditures -35,000, giving a free cash flow of -1.69 million.
| Operating Cash Flow | -1.66M |
| Capital Expenditures | -35,000 |
| Free Cash Flow | -1.69M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 59.97%, with operating and profit margins of -26.18% and -20.72%.
| Gross Margin | 59.97% |
| Operating Margin | -26.18% |
| Pretax Margin | -22.80% |
| Profit Margin | -20.72% |
| EBITDA Margin | -20.36% |
| EBIT Margin | -26.18% |
| FCF Margin | -27.61% |
Dividends & Yields
Abingdon Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Abingdon Health has an Altman Z-Score of -0.92. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.92 |
| Piotroski F-Score | n/a |